Search tips
Search criteria 


Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
Proc R Soc Med. 1977; 70(Suppl 3): 10–12.
PMCID: PMC1543601

Preparation of and clinical experiences with trien for the treatment of Wilson's disease in absolute intolerance of D-penicillamine.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (426K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bucur I, Hasselgren KH. Letter: Treatment of Wilson's disease. Lancet. 1975 Dec 13;2(7946):1218–1218. [PubMed]
  • Dixon HB, Gibbs K, Walshe JM. Preparation of triethylenetetramine dihydrochloride for the treatment of Wilson's disease. Lancet. 1972 Apr 15;1(7755):853–853. [PubMed]
  • Dubois RS, Rodgerson DO, Slovis TL, Hambidge KM, Bianchi TA. Triethylene tetramine dihydrochloride in Wilson's disease. Lancet. 1970 Oct 10;2(7676):775–775. [PubMed]
  • Gelmers HJ, Troost J, Willemse J. Wilson's disease: modification by L-DOPA. Neuropadiatrie. 1973 Dec;4(4):453–457. [PubMed]
  • Gibbs K, Walshe JM. Letter: Treatment of Wilson's disease. Br Med J. 1975 Dec 20;4(5998):706–706. [PMC free article] [PubMed]
  • Lyle WH. Letter: More on "orphan" drugs. N Engl J Med. 1975 Apr 10;292(15):813–814. [PubMed]
  • Peterson CM, Cerami A. Letter: "Orphan-drug" development - whose responsibility? N Engl J Med. 1975 Jan 16;292(3):162–162. [PubMed]
  • Walshe JM. Management of penicillamine nephropathy in Wilson's disease: a new chelating agent. Lancet. 1969 Dec 27;2(7635):1401–1402. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press